scholarly journals Atypical Antipsychotic Use Among Long-Term Care Residents with Parkinson's Disease and Comorbid Depression

2018 ◽  
Vol 21 ◽  
pp. S204
Author(s):  
F Chekani ◽  
ML Johnson ◽  
H Chen ◽  
JT Sherer ◽  
HM Holmes ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Atypical Antipsychotic ◽  
Long Term Care ◽  
Comorbid Depression ◽  
Term Care

scholarly journals Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression

2020 ◽  
Vol Volume 12 ◽  
pp. 23-30 ◽  
Author(s):  
Farid Chekani ◽  
Holly M Holmes ◽  
Michael L Johnson ◽  
Hua Chen ◽  
Jeffrey T Sherer ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Atypical Antipsychotics ◽  
Long Term Care ◽  
Comorbid Depression ◽  
Term Care

Telehealth for patients with Parkinson’s disease: delivering efficient and sustainable long-term care

2016 ◽  
Vol 44 (2) ◽  
pp. 92-97 ◽  
Author(s):  
Peter J. Barbour ◽  
Jill Arroyo ◽  
Star High ◽  
Lisa B. Fichera ◽  
Marie M. Staska-Pier ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Long Term Care ◽  
Term Care

Management of Neuropsychiatric Symptoms in Long-Term Care Residents with Parkinson’s Disease

Drugs & Aging ◽  
2012 ◽  
Vol 30 (1) ◽  
pp. 19-22 ◽  
Author(s):  
Nathan Herrmann ◽  
Connie Marras ◽  
Hadas D. Fischer ◽  
Xuesong Wang ◽  
Geoff M. Anderson ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Long Term Care ◽  
Neuropsychiatric Symptoms ◽  
Term Care

Managing parkinson’s disease in long-term care

2003 ◽  
Vol 15 (8) ◽  
pp. 38-38
Author(s):  
Barbara Jamera
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Long Term Care ◽  
Term Care

scholarly journals PND34 DISEASE BURDEN AND TREATMENT PATTERNS OF PARKINSON'S DISEASE IN A LONG TERM CARE SETTING

2009 ◽  
Vol 12 (3) ◽  
pp. A196
Author(s):  
S Narayanan ◽  
ML Tarrants ◽  
J Castelli-Haley
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Disease Burden ◽  
Care Setting ◽  
Long Term Care ◽  
Treatment Patterns ◽  
Term Care

Managing Parkinson’s disease in long-term care

2002 ◽  
Vol 14 (9) ◽  
pp. 23-29 ◽  
Author(s):  
Sue Thomas ◽  
Doug MacMahon
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Long Term Care ◽  
Term Care

Treatment Patterns With Antipsychotics in Long-Term Care Patients With Parkinson’s Disease Psychosis

2021 ◽  
pp. 073346482098703
Author(s):  
Nazia Rashid ◽  
Andrew Shim ◽  
Sherry Andes ◽  
Sonja Quale ◽  
Victor Abler
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Long Term Care ◽  
Multivariate Regression Analysis ◽  
Treatment Patterns ◽  
Treatment Change ◽  
Term Care ◽  
Bladder Disorders ◽  
Tract Infections

This study assessed treatment change patterns in Parkinson’s disease psychosis (PDP) residents receiving antipsychotic (AP) therapies in U.S. long-term care (LTC) facilities. Residents with PDP in LTC between 01/01/13 and 06/30/16 were identified with ≥1 claim of psychosis, hallucinations, or delusions after PD diagnosis. Treatment patterns were evaluated during the 12 months post index. We identified 864 PDP residents: 408 (47.2%) on AP therapy and 456 (52.8%) on no AP therapy. A total of 335 residents (82.1%) continued, 13 (3.2%) discontinued, 11 (2.7%) switched, and 49 (12.0%) augmented (used ≥2 APs) their index AP therapy. Based on the multivariate regression analysis, younger age, male gender, anemia, anxiolytic use or anxiety, sedatives/hypnotic use, bladder disorders including urinary tract infections, coronary conditions, diabetes, hypertension, and dementia were associated with a higher likelihood of treatment change. Understanding the factors associated with treatment change may inform ways to improve management of PDP in the U.S. LTC setting.

scholarly journals Effects of physician visit frequency for Parkinson’s disease treatment on mortality, hospitalization, and costs: a retrospective cohort study

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Takako Fujita ◽  
Akira Babazono ◽  
Sung-a Kim ◽  
Aziz Jamal ◽  
Yunfei Li
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Survival Time ◽  
Physician Visit ◽  
Long Term Care ◽  
Disease Treatment ◽  
Term Care ◽  
Physician Visits ◽  
Visit Frequency

Abstract Background The number of patients with Parkinson’s disease among older adults is rapidly increasing. Such patients mostly take medication and require regular physician visits. However, the effect of physician visit frequency for the treatment for Parkinson’s disease has not been evaluated. This study aimed to evaluate the impact of physician visit frequency for Parkinson’s disease treatment on mortality, healthcare days, and healthcare and long-term care costs among older adults. Methods This study employed a retrospective cohort design utilizing claims data from the Fukuoka Prefecture Wide-Area Association of Latter-Stage Elderly Healthcare Insurance and Long-Term Care Insurance. Patients aged ≥75 years who were newly diagnosed with Parkinson’s disease in 2014 were included in this study, following the onset of Parkinson’s disease to March 31, 2019. We calculated the restricted mean survival time to evaluate mortality, focusing on the frequency of physician visits for Parkinson’s disease treatment. Inpatient days, outpatient days, and healthcare and long-term care costs per month were calculated using a generalized linear model. Results There were 2224 participants, with 46.5% mortality among those with a higher frequency of physician visits and 56.4% among those with a lower frequency of physician visits. A higher frequency of physician visits was associated with a significant increase in survival time (1.57 months at 24 months and 5.00 months at 60 months) after the onset of Parkinson’s disease and a decrease in inpatient days and healthcare costs compared to a lower frequency of physician visits. Conclusions A higher frequency of physician visits was significantly associated with longer survival time, fewer inpatient days, and lower healthcare costs. Caregivers should support patients with Parkinson’s disease to visit physicians regularly for their treatment.

Sign in / Sign up

Export Citation Format

Share Document